Adult Immunization 2015: Our Performance Review

Sandra Adamson Fryhofer, MD


February 05, 2015

In This Article

HPV Vaccination Coverage: Improved, but Only for Males

Three doses of HPV vaccine are recommended for all females aged 11 through 26; males aged 11 through 21; males aged 22 through 26 who have sex with other men; and for immunocompromised males, including those with HIV.[15]

HPV vaccination (at least one dose) coverage for females (aged 19-26) of 36.9% is similar to 2012 estimates, but vaccination coverage of 5.9% for males (aged 19-26) demonstrates a somewhat encouraging 3.6% increase in coverage.[1] The HPV vaccine is a prophylactic vaccine and must be given before exposure to the virus to be protective.[15]

At the time of this survey, only two HPV vaccines were available: HPV-2 (FDA-approved only for females) and HPV-4 (FDA-approved for both males and females).[15] A 9-valent HPV vaccine, Gardasil® 9, was FDA-approved in December 2014.[16] Look for future guidance from ACIP about how to incorporate this new vaccine into the schedule.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.